U.S. Medical Tapes And Bandages Market Trends and Insights
Chronic Wound and Diabetes Burden Creating Persistent Volume Demand
The United States medical tapes and bandages market experiences steady demand due to the high prevalence of chronic wounds and diabetes. In 2025, chronic wounds impacted 10.5 million Medicare beneficiaries, generating USD 22.5 billion in annual care costs, with wound dressings comprising a significant share. Additionally, 53.1 million Americans with diabetes faced a 15%-34% lifetime risk of diabetic foot ulcers, driving recurring demand for securement tapes, bordered dressings, and bandage systems. These products are consumed over extended treatment cycles, ensuring consistent demand despite reimbursement challenges.High Surgical and ASC Procedure Volumes Sustaining Core Tape and Bandage Demand
The United States medical tapes and bandages market benefits from the growing shift of procedures to ambulatory surgery centers (ASCs). In 2024, 6,436 Medicare-certified ASCs performed 6.4 million fee-for-service Medicare procedures, with a 3.5% year-over-year increase in procedure volume per 1,000 beneficiaries. Rising total knee and hip arthroplasty volumes, along with the 2026 ASC Covered Procedure List expansion adding 560 procedures, further boost demand for wound covering and securement products in outpatient settings.2026 CMS Payment Reset Reshaping Office Wound Care Economics
The United States medical tapes and bandages market is experiencing a major payment shift in office-based wound care. Under the CY 2026 Physician Fee Schedule final rule, CMS reclassified several skin substitutes as "incident-to" supplies and introduced a flat national payment rate of USD 127.28 per square centimeter, replacing the previous ASP+6% structure that allowed reimbursements exceeding USD 2,000 per square centimeter. This change is expected to reduce gross Medicare fee-for-service spending on skin substitute services by USD 19.6 billion in 2026, significantly altering advanced wound treatment economics. While physician offices may shift toward conventional wound products, the disruption could delay product decisions as workflows adjust, creating short-term uncertainty in purchasing behavior.Other drivers and restraints analyzed in the detailed report include:
- Wearable Medical Devices Redefining Adhesive Tape Specifications
- Payer-Driven Home Care Migration Expanding Alternate-Site Product Needs
- GPO Consolidation Compressing Institutional Tape and Bandage Margins
Segment Analysis
In 2025, Medical Bandages accounted for 38.45% of revenue, leading the United States medical tapes and bandages market. Their dominance stems from extensive use in post-operative care, compression support, first-aid treatment, and routine wound covering across hospitals, ASCs, physician offices, retail stores, and homes. Serving both institutional and consumer needs, bandages maintain stable demand across clinical and over-the-counter channels.Medical Tapes, the fastest-growing segment, is projected to achieve an 8.25% CAGR from 2026 to 2031. Growth is driven by increased adoption of CGMs, insulin pumps, and advanced tape formats like transparent film securement and silicone tapes. Enhanced focus on adhesion, skin tolerance, and removal comfort is driving innovation in this segment.
Surgical wounds contributed 35.66% of revenue in 2025, making them the largest application in the United States medical tapes and bandages market. This is linked to the high volume of outpatient and ambulatory procedures requiring post-treatment care, creating consistent demand for tapes, dressings, and bandages.
Ulcer Treatment, the fastest-growing application, is expected to post a 7.95% CAGR from 2026 to 2031. Growth is fueled by the diabetic population and demand for conventional wound care in managing diabetic, pressure, and venous ulcers. CMS payment changes in 2026 are further driving demand for foam dressings and securement tapes.
Complete Report Scope:
- By Product
- Medical Tapes
- Paper Tapes
- Fabric Tapes
- Plastic Tapes
- Silicone / Acrylic / Rubber Tapes
- Transparent Film / Dressing Retention Tapes
- Elastic / Waterproof / Specialty Tapes
- Dressings
- Foam Dressings
- Hydrocolloid Dressings
- Film Dressings
- Alginate Dressings
- Hydrogel Dressings
- Collagen Dressings
- Superabsorbent Dressings
- Antimicrobial Dressings
- Other Advanced Dressings
- Medical Bandages
- Adhesive Bandages / First Aid Bandages
- Gauze Bandage Rolls
- Elastic Bandage Rolls
- Cohesive / Self-Adherent Bandages
- Conforming Bandages
- Triangular Bandages
- Orthopedic / Cast Bandages
- Others
- Medical Tapes
- By Application
- Surgical Wounds
- Traumatic Wounds
- Ulcers Treatment
- Sports Injuries
- Burn Injuries
- Sport Injuries
- Others
- By End User
- Hospitals
- Ambulatory Surgery Centers
- Clinics and Physician Offices
- Home Healthcare
- Long-Term Care and Skilled Nursing Facilities
- Retail / Consumer Self-Care
- Military and Emergency Care
- By Distribution Channel
- Distributors
- Direct Sales / Enterprise Contracts
- Retail Pharmacies
- E-commerce / Online Medical Supply
- Others
List of Companies Covered in this Report:
- AERO Healthcare
- B. Braun
- Cardinal Health
- Coloplast
- Convatec Group plc
- DeRoyal Industries
- Dukal
- Dynarex
- Essity Health & Medical
- HALYARD
- Hartmann Group
- Integra LifeSciences
- Kenvue Brands LLC
- Mckesson
- Medline Industries
- Medtronic
- Molnlycke Health Care
- Smiths Group
- Solventum Corporation
- Urgo Medical North America LLC
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AERO Healthcare
- B. Braun SE
- Cardinal Health Inc.
- Coloplast A/S
- Convatec Group plc
- DeRoyal Industries Inc.
- Dukal
- Dynarex
- Essity Health & Medical
- HALYARD
- HARTMANN USA, Inc.
- Integra LifeSciences Holdings Corporation
- Kenvue Brands LLC
- McKesson Corporation
- Medline Industries Inc.
- Medtronic plc
- Molnlycke Health Care AB
- Smith & Nephew plc
- Solventum Corporation
- Urgo Medical North America LLC

